Stochastic multi-scale models of competition within heterogeneous
  cellular populations: simulation methods and mean-field analysis by de la Cruz, Roberto et al.
Stochastic multi-scale models of competition within
heterogeneous cellular populations: simulation methods
and mean-field analysis
Roberto de la Cruza,b, Pilar Guerreroc, Fabian Spilld,e, Toma´s Alarco´nf,a,b,g
aCentre de Recerca Matema`tica, Edifici C, Campus de Bellaterra, 08193 Bellaterra (Barcelona),
Spain.
bDepartament de Matema`tiques, Universitat Auto`noma de Barcelona, 08193 Bellaterra
(Barcelona), Spain.
cDepartment of Mathematics, University College London, Gower Street, London WC1E 6BT, UK
dDepartment of Mechanical Engineering, Massachusetts Institute of Technology, 77
Massachusetts Avenue, Cambridge, MA 02139, USA.
eDepartment of Biomedical Engineering, Boston University, 44 Cummington Street, Boston MA
02215, USA.
fICREA (Institucio´ Catalana de Recerca i Estudis Avanc¸ats), Barcelona, Spain.
gBarcelona Graduate School of Mathematics (BGSMath), Barcelona, Spain.
Abstract
We propose a modelling framework to analyse the stochastic behaviour of hetero-
geneous, multi-scale cellular populations. We illustrate our methodology with a
particular example in which we study a population with an oxygen-regulated pro-
liferation rate. Our formulation is based on an age-dependent stochastic process.
Cells within the population are characterised by their age (i.e. time elapsed since
they were borne). The age-dependent (oxygen-regulated) birth rate is given by a
stochastic model of oxygen-dependent cell cycle progression. Once the birth rate
is determined, we formulate an age-dependent birth-and-death process, which dic-
tates the time evolution of the cell population. The population is under a feedback
loop which controls its steady state size (carrying capacity): cells consume oxy-
gen which in turns fuels cell proliferation. We show that our stochastic model of
cell cycle progression allows for heterogeneity within the cell population induced
by stochastic effects. Such heterogeneous behaviour is reflected in variations in
the proliferation rate. Within this set-up, we have established three main results.
First, we have shown that the age to the G1/S transition, which essentially de-
termines the birth rate, exhibits a remarkably simple scaling behaviour. Besides
the fact that this simple behaviour emerges from a rather complex model, this
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allows for a huge simplification of our numerical methodology. A further result
is the observation that heterogeneous populations undergo an internal process of
quasi-neutral competition. Finally, we investigated the effects of cell-cycle-phase
dependent therapies (such as radiation therapy) on heterogeneous populations. In
particular, we have studied the case in which the population contains a quiescent
sub-population. Our mean-field analysis and numerical simulations confirm that,
if the survival fraction of the therapy is too high, rescue of the quiescent popula-
tion occurs. This gives rise to emergence of resistance to therapy since the rescued
population is less sensitive to therapy.
Keywords: multi-scale modelling, stochastic population dynamics, cell cycle,
radiotherapy, scaling laws
1. Introduction
Global cell traits and behaviour in response to stimuli, the so-called phenotype,
results from a complex network of interactions between genes and gene products
which ultimately regulates gene expression. These networks of gene regulation
constitute non-linear, high-dimensional dynamical systems whose structure has
been shaped up by evolution by natural selection, so that they exhibit properties
such as robustness (i.e. resilience of the phenotype against genetic alterations)
and canalisation (i.e. the ability for phenotypes to increase their robustness as
time progresses). These properties are exploited by tumours to increase their pro-
liferative potential and resist to therapies [1]. In addition to complex, non-linear
interactions within individual cells, there exist intricate interactions between dif-
ferent components of the biological systems at all levels: From complex signalling
pathways and gene regulatory networks to complex non-local effects where per-
turbations at whole-tissue level induce changes at the level of the intra-cellular
pathways of individual cells [2, 3, 4, 5, 6, 7, 8]. These and other factors contribute
towards a highly complex dynamics in biological tissues which is an emergent
property of all the layers of complexity involved.
To tackle such complexity, multi-scale models of biological systems as diverse
as cardiac systems [9, 10, 11, 12], systems of developmental biology [13, 14, 15,
16, 17], and tumour growth systems [2, 18, 3, 4, 19, 20, 21, 22, 23, 5, 24, 6,
25, 26, 27, 7, 28, 29, 30, 31, 8] have been developed. In parallel to the model
development, algorithms and analytic methods are being developed to allow for
more efficient analysis and simulation of such models [32, 33, 34, 35].
In the case of cancer biology, the multi-scale interactions of intracellular changes
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at the genetic or molecular pathway level and tissue-level heterogeneity can con-
spire to generate unfortunate effects such as resistance to therapy [36, 37, 38, 29,
39]. Heterogeneity plays a major role in the emergence of drug resistance within
tumours and can be of diverse types. There is heterogeneity in cell types due
to increased gene mutation rate as a consequence of genomic instability and other
factors [36, 38, 29, 39]. Heterogeneity can also be caused by the complexity of the
tumour microenvironment [40, 37, 29], in which diverse factors such as tumoural
or immune cells [41, 42], or the extracellular matrix and its physical properties
[43], strongly influence cancer cell behaviour. Note that hypoxia is also known
to change the tumour microenvironment [43]. In either case, heterogeneity within
the tumour creates the necessary conditions for resistant varieties to emerge and
be selected upon the administration of a given therapy.
The main aim of this paper is to analyse the properties of heterogeneous pop-
ulations under the effects of fluctuations both within the intracellular pathways
which regulate (individual) cell behaviour and those associated to intrinsic ran-
domness due to finite size of the population. To this purpose, we expand upon
the stochastic multi-scale methodology developed in [44], where it was shown
that such a system can be described by an age-structured birth-and-death process.
The coupling between intracellular and the birth-and-death dynamics is carried
out through a novel method to obtain the birth rate from the stochastic cell-cycle
model, based on a mean-first passage time approach. Cell proliferation is assumed
to be activated when one or more of the proteins involved in the cell-cycle reg-
ulatory pathway hit a threshold. This view allows us to calculate the birth rate
as a function of the age of the cell and the extracellular oxygen in terms of the
associated mean-first passage time (MFPT) problem [45]. The present approach
differs from that in [44] in that our treatment of the intracellular MFPT is done in
terms of a large deviations approach, the so-called optimal path theory [46].
This methodology allows us to explore the effects of intrinsic fluctuations
within the intracellular dynamics, in particular a model of the oxygen-regulated
G1/S which dictates when cells are prepared to divide, as a source of heteroge-
neous behaviour: fluctuations induce variability in the birth rate within the popu-
lation (even to the point of rendering some cells quiescent, i.e. stuck in G0) upon
which a cell-cycle dependent therapy acts as a selective pressure.
This paper is organised as follows. Section 2 provides a summary of the struc-
ture of the multi-scale. In Section 3, we give a detailed discussion of the intracel-
lular dynamics, i.e. the stochastic model of the oxygen-regulated G1/S transition,
and its analysis. In Section 4, we summarise the formulation of the age-structured
birth-and-death process, the numerical simulation technique, and the mean-field
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Figure 1: Schematic representation of the different elements that compose our multi-scale model.
We show the different levels of biological organisation as well as associated characteristic time
scales [44] associated to each of these layers: resource scale, i.e. oxygen which is supplied at a
constant rate and consumed by the cell population, cellular scale, i.e. oxygen-regulated cell cycle
progression which determines the age-dependent birth rate into the cellular layer, and, finally, the
cellular scale, which is associated to the stochastic population dynamics.
analysis of a homogeneous population. In Section 5, we discuss how noise within
the intracellular dynamics induces heterogeneity in the population and analyse
the stochastic dynamics of competition for a limited resource within such hetero-
geneous populations. In Section 6 we further study the effects of noise-induced
heterogeneity on the emergence of drug resistance upon administration of a cell
cycle-specific therapy. Finally, in Section 7 we summarise our results and discuss
our conclusions as well as avenues for future research.
2. Summary of the multi-scale model
Before proceeding with a detailed discussion of the different elements in-
volved in the formulation of the stochastic multi-scale model, it is useful to pro-
4
vide a general overview of the overall structure of the model, which is closely
related to that of the model proposed in [2].
The model we present in this article integrates phenomena characterised by
different time scales, as schematically shown in Fig. 1. This model intends to
tackle the growth and competition of cellular populations under the restriction of
finite amount of available resources (in this case, oxygen) supplied at a finite rate,
S¯.
The general approach used in this model is a natural generalisation of the
standard continuous-time birth-and-death Markov process and its description via
a Master Equation [47]. As we will see, the consideration of the multi-scale char-
acter of the system, i.e. the inclusion of the physiological structure associated
with the cell-cycle variables, introduce an age-structure within the population: the
birth rate depends on the age of cell (i.e. time elapsed since last division) which
determines, through the corresponding cell-cycle model, the cell-cycle status of
the corresponding cells.
The evolution of the concentration of oxygen, c(t), (resource scale, see Fig.
1) is modelled by:
dc
dt
= S¯ − k¯c
NT∑
i=1
Ni(t) (1)
where NT is the number of cellular types consuming the resource c, and Ni(t),
i = 1, . . . , NT , is the number of cells of type i at time t. Note that, in general,
Ni(t) is a stochastic process, and, therefore, in principle Eq. (1) should be treated
as a stochastic differential equation [48].
The second sub-model considered in our multi-scale model, associated with
the intracellular scale (see Fig. 1), is an stochastic model of oxygen-regulated
cell-cycle progression. This sub-model is formulated using the standard tech-
niques of chemical kinetics modelling [49] so that the mean-field limit of the
stochastic model corresponds to the deterministic cell-cycle model formulated in
[50]. This model provides the physiological state of the cell in terms of the num-
ber of molecules of each protein involved in the cell-cycle of a cell of a given
age, a. From such physiological state, we derive whether the G1/S transition
has occurred. The cell-cycle status of a cell of age a is determined in terms of
whether the abundance of certain proteins which activate the cell-cycle (cyclins)
have reached a certain threshold. In our particular case, if at age a, the cyclin
levels are below the corresponding threshold, the cell is still in G1. If, on the con-
trary, the prescribed threshold level has been reached, the cell has passed onto S,
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and therefore is ready to divide. This implies that the probability of a cell having
crossed the threshold of cyclin levels at age a can be formulated in terms of a
mean first-passage time problem (MFTP) in which one analyses the probability
of a Markov process to hit a certain boundary [45, 47]. Unlike our approach in
[44], based on approximating the full probability distribution of the stochastic cell
cycle model, in the present approach, passage time is (approximately) solved in
terms of an optimal trajectory path approach [46].
At the interface between the intracellular and cellular scales sits our model of
the (age-dependent) birth rate, which defines the probability of birth per unit time
(cellular scale) in terms of the cell cycle variables (intracellular scale). The rate
at which our cell-cycle model hits the cyclin activation threshold, i.e. the rate at
which cells undergo G1/S transition, is taken as proportional to the birth rate. In
particular, the birth rate is taken to be function of the age of the cell as well as the
concentration of oxygen, as the oxygen abundance regulates the G1/S transition
age, aG1/S(c), i.e. the time (age) elapsed between the birth of a cell and its G1/S
transition:
b(a) = τ−1p H(a− aG1/S(c)). (2)
i.e. cell division occurs at a constant rate, τ−1p , provided cells have undergo the
G1/S transition and H is the Heaviside function. In other words, we consider
that the duration of the G1 phase is regulated by the cell cycle model, whereas
the duration of the S-G2-M is a random variable, exponentially distributed with
average duration equal to τp (see Fig. 1).
The third and last sub-model is that associated with the cellular scale. It corre-
sponds to the dynamics of the cell population and it is governed the Master Equa-
tion for the probability density function of the number of cells [47]. The stochastic
process that describes the dynamics of the population of cells is an age-dependent
birth-and-death process where the birth rate is given by Eq. (2) where aG1/S(c)
is provided by the intracellular model. The death rate is, for simplicity, consid-
ered constant. As a consequence of the fact that the birth rate is age-dependent,
our Multi-Scale Master Equation (MSME) does not present the standard form for
unstructured populations, rather, it is an age-dependent Master Equation.
A detailed description of each sub-model and its analysis is given in Sections
3 and 4.
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3. Intracellular scale: Stochastic model of the oxygen-regulated G1/S transi-
tion
3.1. Biological background
Cell proliferation is orchestrated by a complex network of protein and gene
expression regulation, the so-called cell cycle, which accounts for the timely co-
ordination of proliferation with growth and, by means of signalling cues such as
growth factors, tissue function [51]. Dysregulation of such orderly organisation
of cell proliferation is one of the main contributors to the aberrant behaviour ob-
served in tumours [52].
The cell cycle has the purpose of regulating the successive activation of the so-
called cyclin-dependent kinases (CDKs) which control the progression along the
four phases of cycle: G1 (first gap phase), S (DNA replication), G2 (second gap
phase), and M (mitosis) [53, 54, 55]. This four phases must be supplemented with
a fifth, G0, which account for cells that are quiescent due to lack of stimulation
(i.e. absence of growth factors, lack of basic nutrients, etc.) to proliferate. Re-
cent models of the cell cycle organise the complex regulatory network into CDK
modules, each centred around a cyclin-CDK complex which is key for the tran-
sition between the cell cycle phases (see, for example, [53]): cyclin D/CDK4-6
and cyclin E/CDK2 regulate progression during the G1 phase and elicit the G1/S
transition, cyclin A/CDK2 promote progression during S phase and orchestrates
the S/G2 transition, and, finally, cyclin B/CDK2 brings about the G2/M transi-
tion. The activity of each of these cyclin-CDK complexes is regulated in a timely
manner, so that each phase of the cell cycle ensues at the proper time, by means
of transcriptional regulation, postranscriptional modifications (e.g. phosphory-
lation), and degradation (via ubiquitination) in which a large number of other
components participate, including transcription factors, enzymes, ubiquitins, etc.
In the present paper, we propose a coarse-grained description of the cell cycle
phases by lumping S, G2, and M into one phase, so that we consider a two-phase
model G1 and S-G2-M, as shown in Fig. 1, [56]. In particular, we consider that
cells can only divide once they have entered the S-G2-M phase at a constant rate.
Entry in S-G2-M is regulated by a (stochastic) model of the G1/S transition which
takes into account the regulation of the duration of the G1 phase by hypoxia (lack
of oxygen).
The abundance of oxygen is known to be one of the factors that regulate the
duration of the G1 phase of the cell cycle. The issue of the regulation of the
G1/S transition by the oxygen concentration has been the subject of several mod-
elling studies [56, 50]. These models focus on the hypoxia-induced delay of the
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activation of the cyclins either through activation of cyclin inhibitors [56] or via
up-regulation of the HIF-1α transcription factor [50]. From the modelling point
of view, both of them are mean-field models, thus neglecting fluctuations. In this
Section, we formulate a stochastic version of the model of Bedessem & Stephanou
[50], of which an schematic representation is shown in Fig. 2.
HIF-1 mediates adaptive responses to lack of oxygen [57]. HIF-1 is a het-
erodimer consisting of two sub-units: HIF-1α and HIF-1β. Whilst the latter is
constitutively expressed, HIF-1α is O2-regulated. In the presence of adequate
oxygen availability is negatively regulated by the von Hippel-Lindau (VHL) tu-
mour suppressor protein, which allows HIF-1α for degradation. VHL loss-of-
function mutations are usual in many types of tumours, which allows for de-
regulated HIF-1α degradation [57]. HIF-1 is involved in a number of cellular
responses including switch from oxidative phosphorylation to glycolysis, activa-
tion of angiogenic pathways, and inhibition of cell cycle progression [58, 57].
3.2. Mean-field model of the regulation of the G1/S transition by hypoxia
Bedessem & Stephanou formulate a model of the effect of hypoxia (mediated
by HIF-1) on the timing of the G1/S transition [50]. The involvement of HIF-
1 in cell cycle regulation is complex and not completely understood. There is
evidence that HIF-1 delays entry into S(-G2-M) phase by activating p21, a CDK
inhibitor, [59, 60]. HIF-1 up-regulation of p21 mediates indirect down-regulation
of cyclin E [61]. Further to HIF-1 regulation of the cell cycle, there exists a
feedback regulation of cell cycle proteins of HIF-1. Hubbi et al. [62] report that
CDK1 and CDK2 physically and functionally interact with HIF-1α: CDK1 down-
regulates lysosomal degradation of HIF-1α, thus consolidating its stability and
promoting its transcriptional activity. On the contrary, CDK2 activates lysosomal
degradation of HIF-1α and promotes G1/S transition. Bedessem & Stephanou
[50] do not take into account all these issues and, for simplicity, chose to focus on
the well-documented effect of HIF-1 on cyclin D [63, 60].
Bedessem & Stephanou [50] model formulation is based on the following as-
sumptions:
1. The G1/S is modelled by a biological switch which emerges from the mutual
inhibition between a cyclin (in this case, cyclin E) and an ubiquitin com-
plex (SCF complex): The latter marks the former for degradation whereas
cyclin E mediates inactivation of the SCF complex. This mutual inhibition
gives rise to a bistable situation in which two stable fixed points coexist,
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each associated with the G1 phase (high SCF activity, low cyclin E concen-
tration) and the S-G2-M phase (low SCF activity, high cyclin E concentra-
tion). Activation and inactivation of the SCF complex are assumed to follow
Michaelis-Menten kinetics.
2. As in previous models [64, 65, 56], the G1/S transition is brought about by
triggering a saddle-node bifurcation, whereby the G1 phase fixed point col-
lides with the unstable saddle, driving the system into S-G2-M fixed point.
Two factors drive the system through this bifurcation: cell growth (logistic
increase of the cell mass [64]) and activation of the E2F transcription factor.
In [50], both factors are taken to up-regulate the transcription of cyclin E.
3. Activation of E2F is modelled in terms of the E2F-Retinoblastoma protein
(RBP) switch [66]. Briefly, E2F is captured (bound) by unphosphorylated
RBP. Upon phosphorylation, RBP releases E2F which activates transcrip-
tion of G1/S-transition promoting cyclins, such as cyclin E [67]. Further,
E2F can be in unphosphorylated (active) form and phosphorylated (inac-
tive) form. Following [65], Bedessem & Stephanou assume that fraction of
active E2F and RBP-bound E2F are in adiabatic equilibrium with unphos-
phorylated RBP and total free E2F [50]. Furthermore, [50] takes cyclin D
to phosphorylate RBP.
4. Last, Bedessem & Stephanou [50] assume that HIF-1α inhibits synthesis
of cyclin D. Following experimental evidence reported in [63], they assume
that the level of HIF-1α depends exponentially of the oxygen concentration.
These basic hypotheses are primarily based on previous models [64, 65, 56]. The
resulting pathway is schematically represented in Fig. 2.
3.3. Stochastic G1/S transition model
Based on the hypotheses summarised in Section 3.2, Bedessem & Stephanou
[50] formulated a mean-field model which is able to reproduce such behaviours as
delay of the G1/S due lo lack of oxygen as well as hypoxia-induced quiescence.
Here, we present a stochastic model (see Fig. 3 and Table 1), whose mean field
limit is the model formulated in [50]. We analyse this model using the stochastic
quasi-steady state approximation we have developed in [32, 34].
The deterministic model formulated in [50], which we have briefly described
in Section 3.2, is based on a series of reactions shown in Fig. 3, which include
Michaelis-Menten kinetics for activation and inactivation of SCF complexes. Our
stochastic model of the G1/S transition builds upon the stochastic (Markovian)
description of the same set of reactions.
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Figure 2: Schematic representation of the elements involved in the model of hypoxia-regulated
G1/S transition proposed by Bedessem & Stephanou [50]. Within the framework of this model,
the negative-feedback between CycE and SCF is the key modelling ingredient for the system to
emulate the behaviour of a cell during the G1/S transition. The relative balance between CycE
(which promotes the G1/S transition) and SCF (G1/S transition inhibitor) is regulated by growth
and hypoxia, so that the timing of the transition depends upon these two factors.
Our model is predicated on the stochastic dynamics of the state vector being
described by a point process [68, 69], whereby the state of the system, X , changes
by an amount ri when the elementary reaction i occurs. If we further assume that
the waiting time between events is exponentially distributed, the process is char-
acterised by the associated transition rates, i.e. P (X(a + ∆a) = X + ri|X(a) =
X) = Wi(X)∆a+O(∆a
2). Using law of mass action [49] as our basic modelling
framework, the transition rates of each elementary process are given in Table 1.
Once we have determined the transition rates associated with each elementary re-
action (or channel), the dynamics of the system is given by the Chemical Master
Equation of a (non-structured) Markov Process, X(a):
∂P (X, a)
∂a
=
R∑
i=1
(Wi(X − ri)P (X − ri, a)−Wi(X)P (X, a)) (3)
where P (X, a) is the probability of the state vector of the system to be X at age,
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Variable Description
X1, X8 Number of CyclinD and CyclinE molecules (respectively)
X2, X5 Number of inactive and active SCF molecules (respectively)
X3, X6 Number of SCF-activating and SCF-inactivating enzyme molecules (respectively)
X4, X7 Number of enzyme-inactive SCF and enzyme-active SCF complexes (respectively)
X9, X10 Number of free RbP and E2F molecules (respectively)
Reaction probability p.u.t ri
W1 = k1 − k2[H] (1, 0, 0, 0, 0, 0, 0, 0, 0, 0)
W2 = k3X1 (−1, 0, 0, 0, 0, 0, 0, 0, 0, 0)
W3 = k4X2X3 (0,−1,−1, 1, 0, 0, 0, 0, 0, 0)
W4 = k5X4 (0, 1, 1,−1, 0, 0, 0, 0, 0, 0)
W5 = k9X8X7 (0, 1, 0, 0, 0, 1,−1, 0, 0, 0)
W6 = k6X4 (0, 0, 1,−1, 1, 0, 0, 0, 0, 0)
W7 = k7X5X8X6 (0, 0, 0, 0,−1,−1, 1, 0, 0, 0)
W8 = k8X8X7 (0, 0, 0, 0, 1, 1,−1, 0, 0, 0)
W9 = k10m
(
1− X9
[E2F ]tot
)
X10 (0, 0, 0, 0, 0, 0, 0, 1, 0, 0)
W10 = (k11 + k12X5)X8 (0, 0, 0, 0, 0, 0, 0,−1, 0, 0)
W11 = k13 (0, 0, 0, 0, 0, 0, 0, 0, 1, 0)
W12 = (k14 + k15X1)X9 (0, 0, 0, 0, 0, 0, 0, 0,−1, 0)
W13 = k16 (0, 0, 0, 0, 0, 0, 0, 0, 0, 1)
W14 = k17X10 (0, 0, 0, 0, 0, 0, 0, 0, 0,−1)
Table 1: Reaction probability per unit time, Wi ≡W (X, ri, t), i = 1, .., 14. The mass is assumed
to grow following a logistic law: m(a) = m∗Ke
ηa
Keηa−1 =
m∗
1−Ke−ηa , where K = 1− m∗m(0) and a is the
age of the cell (i.e. the time elapsed since birth). According to [50], the level of active HIF-1α,
[H], depends exponentially on the extracellular oxygen concentration, c: [H] = H0eβ1(1−c). Fur-
thermore, Following Novak and Tyson [65], we assume that at each time, the active E2F, [E2FA],
is the fraction of unphosphorylated free E2F factor, [E2F ]: [E2FA] =
([E2F ]tot−[E2FRb])[E2F ]
[E2F ]tot
.
The equilibrium between E2F-Rb complexes; free E2F and free Rb is given by [65]: [E2FRb] =
[Rb] = 2[E2F ]tot[Rb]
[E2F ]tot+[Rb]+
√
([E2F ]tot+[Rb])2−4[E2F ]tot[Rb]
i.e. the time reckoned from the last division, a. The transition rates, Wi(X), the
vectors ri (whose components are the variation of the number of each chemical
species upon occurrence of reaction i) are given in Table 1 and determine the
dynamics of the system.
Even for moderately complex models, Eq. (3) has no solution in closed form.
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Figure 3: Reactions for the stochastic version of the model proposed by Bedessem & Stephanou
[50]. The reactions correspond (from top to bottom): hypoxia-inhibited synthesis and degradation
of CycD, enzyme-catalysed, CycE-mediated inactivation of SCF, enzyme-catalysed activation of
SCF, synthesis (regulated by growth and active E2F) and degradation (up-regulated by active SCF)
of CycE, synthesis and degradation of Rb, and, last, synthesis and degradation of E2F. The negative
feedback (mutual inhibition) between SCF and CycE mediates bistable behaviour in this model of
the G1/S transition. Some of the transition rates associated to the reactions shown in are not
constant but depend on the number of molecules of chemical species i present at a particular time,
Xi. For the definition of the quantities Xi, we refer the reader to Table 1.
Therefore, in order to study the properties of the system one must resort to numer-
ical simulation (Monte Carlo) or asymptotic approximations. In the next section,
we present an asymptotic analysis based on a recently developed form of stochas-
tic quasi-steady state approximation.
3.4. Semi-classical quasi-steady state analysis of the stochastic G1/S transition
model
In [32, 34, 70], we have developed a stochastic version of the classical QSS ap-
proximation, the so-called semi-classical QSS approximation (SCQSSA) which,
within the framework of the optimal path theory, allows us to tackle systems which
exhibit separation of time scales, such as enzyme-catalysed reactions. Since these
type of reaction features prominently in our stochastic model of the hypoxia-
regulated G1/S transition (see Fig. 3), we will use the SCQSSA to analyse the
effects of intrinsic noise on the stochastic model of the hypoxia-regulated G1/S
transition (as determined by the transition rates shown in Table 1). This approx-
imation allows us to study noise-induced phenomena which are relevant for the
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timing of the G1/S transition and, therefore, bear upon the population dynamics.
Following the SCQSSA methodology summarised in Appendix A, we derive
the following set of equations which describe the optimal path associated with the
stochastic G1/S transition model, Table 1:
dq1
da
= κ1 − κ2 − κ3q1 (4)
dq5
da
=
κ6p3pe1(pc − q5)
(pc − q5) + κ5+κ6κ4
− κ9p6pe2q5q8
q5 + (κ8 + κ9)
(5)
dq8
da
= κ10mq10
(
1− q9
[̂e2f ]tot
)
− κ11q8 − κ12q5q8 (6)
dq9
da
= κ13 − κ14q9 − κ15q1q9 (7)
dq10
da
= κ16 − κ17q10 (8)
q2 = pc − q5 (9)
q4 =
pe1q2
q2 +
κ5+κ6
κ4
, q3 + q4 = pe1 (10)
q7 =
pe2q5
q5 + (κ8 + κ9)
, q6 + q7 = pe2 (11)
p3 = cnt. p6 = cnt. (12)
where a is the rescaled age variable a = k7ESt (see Appendix B, Table B.3).
The oxygen dependences enters the model though the [H] dependent parameter
κ2 (see Table B.3-B.4). The reader is referred to Appendix A for a summary of the
method and Appendix B for a detailed derivation of Eqs. (4)-(12) which hereafter
is referred to as the semi-classical quasi-steady state approximation (SCQSSA) of
the stochastic cell-cycle model and to [32, 34] for a full account of the SCQSSA
methodology. Furthermore, since we will be interested in the random effects asso-
ciated to the enzyme-regulated dynamics of SCF, encapsulated in the parameters
p3 and p6, we have taken pi(a) = 1 for all i 6= 3, 6. This corresponds to analysing
the marginal distribution integrating out all the stochastic effects associated to all
Xi with i 6= 3, 6.
3.5. Stochastic behaviour of the G1/S model
We now proceed to study the behaviour of the stochastic model of the oxygen-
regulated G1/S transition. We pay special attention to those aspects in which we
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observe a departure of the stochastic system from the mean-field behaviour. In
particular, we highlight the effects of modifying the relative abundance of SCF-
activating and inactivating enzymes, including the ability of inducing oxygen-
independent quiescence.
3.5.1. The relative abundance of the SCF activating and inactivating enzymes
controls the timing of the G1/S transition
In references [32, 34] we have shown that, under SCQSSA conditions, the mo-
menta p3 and p6, i.e. the momenta coordinates associated with the SCF-activating
and inactivating enzymes, respectively, are determined by the probability distribu-
tion of their initial (conserved) number. In particular, if we assume that the initial
number of SCF-activating and inactivating enzyme molecules, E1 and E2, is dis-
tributed over a population of cells following a Poisson distribution with parameter
E, we have shown that [34]:
p3 =
e1
E
= pe1 , p6 =
e2
E
= pe2 .
With this in mind, we can analyse the effect of changing the relative con-
centration of SCF-activating and inactivating enzymes on the timing of the G1/S
transition. Our results are shown in Figs. 4 and 5. Fig. 4 illustrates that, for a
fixed oxygen concentration, the G1/S transition is delayed by depriving the sys-
tem of SCF-activating enzyme: as the ratio p3/p6 = e1/e2 of SCF activating and
deactivating enzyme increases, the G1/S transition takes longer to occur. Then,
Fig. 5 shows that the G1/S transition age aG1/S(c, p3, p6) decreases when p3/p6
increases. Furthermore, increasing the oxygen concentration c from c = 0.1 to
c = 1 shifts the curve towards lower transition ages aG1/S(c, p3, p6). Note that
this prediction is beyond the reach of the mean-field limit [50].
3.5.2. Induction of quiescence
In view of the results of Section 3.5.1, we have proceeded to a more thorough
analysis of the effect of varying the ratio p3/p6, which we recall that, within the
SCQSSA, is equal to the ratio between the abundance of SCF-activating and in-
activating enzymes, on the behaviour of the SCQSSA system Eqs. (4)-(12). In
particular, we have investigated the bifurcation diagram of Eqs. (4)-(12) with
p3/p6 as the control parameter. Our results are shown in Fig. 6. We observe
that, regardless of the value of m, there exists a range of values of the control
parameter for which the saddle-node bifurcation, which gives rise to the G1/S
transition, does not occur (i.e. only the G1-fixed point is stable). This result im-
plies that depletion of SCF-activating enzyme, or, equivalently, over-expression
14
0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Age (minutes)
R
es
ca
le
d 
nu
m
be
r o
f m
ol
ec
ul
es
p6/p3=0.95
 
 
SCF
cycE
0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Age (minutes)
R
es
ca
le
d 
nu
m
be
r o
f m
ol
ec
ul
es
p6/p3=1.0
 
 
SCF
cycE
Age (minutes)
0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000
R
es
ca
le
d 
nu
m
be
r o
f m
ol
ec
ul
es
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
p 6 /p 3=1.05
SCF
cycE
Figure 4: Series of plots illustrating how the ratio p6/p3, which is associated with the ratio of
the number of SCF-inactivating and SCF-activating enzymes, modulates the timing of the G1/S
transition. Parameter values as given in Table B.4. Initial conditions are provided in Table B.6
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Figure 5: Plot showing how the G1/S transition age, aG1/S(c, p3, p6), changes as the ratio p3/p6,
which is determined by the ratio of the (conserved) amounts of SCF activating and inactivating
enzymes [32, 34], varies. We show aG1/S(c, p3, p6) for c = 1 (blue circles) and c = 0.1 (red
squares). Parameter values as given in Table B.4.
of SCF-inactivating enzyme can stop cell-cycle progression by locking cells into
the so-called G0 state, i.e. quiescence.
These results are confirmed by direct simulation of the stochastic cell-cycle
model (Table 1) using Gillespie’s stochastic simulation algorithm [49], see Fig. 7.
3.6. Scaling theory of the G1/S transition age
We finish our analysis of the intracellular dynamics by formulating a scaling
theory of one of the fundamental quantities in our multi-scale model, namely, the
G1/S transition age, aG1/S(c, p6, p3), which determines the age-dependent birth
rate (see Eq. (2)). In this section, we will show that, in spite of the complexity of
the SCQSSA formulation of the oxygen-dependent cell-cycle progression model
(see Eqs. (4)-(12)), aG1/S exhibits remarkable regularities with respect to its de-
pendence on the oxygen concentration and the cell-cycle parameters p6 and p3.
Such regularities hugely simplify our multi-scale methodology.
We can see this regularity in Figure 8. Figure 8(a) shows aG1/S as a function
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Figure 6: This figure shows the bifurcation diagram of the SCQSSA of the stochastic cell-cycle
model for different values of the parameter m. The ratio p3/p6 is the control parameter. The order
parameter is the steady state value of the generalised coordinate associated with active SCF, q5.
Solid line corresponds to m = 10, dash lines to m = 8 and dotted lines to m = 6. Parameter
values as give in Table B.5, pi = 1, i 6= 3, 6, pc = 1 and c = 1. Blue lines indicate stable steady
state and red lines indicate unstable steady state.
of the ratio
(
c
ccr(p6/p3)
− 1
)
, for six different values of p6
p3
< rcr, where rcr = 1
is the critical value. We see that all graphs fall together on a straight line in
log-log space, indicating a power-law dependence of aG1/S on
(
c
ccr(p6/p3)
− 1
)
.
On the other hand, Figure 8(c) shows the dependence of the normalized func-
tion
aG1/S
(
c,
p6
p3
)
a+(p6/p3)
, on c, for five values p6
p3
> rcr. Here, a+(p6/p3) = aG1/S(c =
0, p6/p3). We see that there is good agreement between the five values p6p3 for
small c, with the disagreement increasing with increasing c. Thus, a good scaling
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Figure 7: Simulation results for the stochastic model of the oxygen-regulated G1/S transition
defined by the transition rates given in Table 1. We have plotted the probability P (X5, T ), where
T = 100, with different values of X3(τ = 0)/X6(τ = 0). 1000 realisations and m=5.0.
approximation for aG1/S is given by
aG1/S
(
c,
p6
p3
)
'
 a+
(
p6
p3
)
e−c/c0 if p6
p3
> rcr
a−
(
c
ccr(p6/p3)
− 1
)−β
if p6
p3
< rcr
(13)
Here, c0, a−, and β are constants. According to our analysis of the data presented
in Figure 8, these constants are given by c0 ' 1.1, a− ' 8.25 · 103 and β ' 0.2.
Likewise, a+(p6/p3) is obtained by fitting to the data presented in Figure 8(d).
The critical oxygen concentration for quiescence ccr can be estimated analytically
(with parameter values taken from Table B.4):
ccr
(
p6
p3
)
= 1− 1
β1
log
(
1
a3H0
(
a1 +
a2d2
d1[e2f ]t
(
1− 1
1− a0(p3p6 )2
)))
(14)
where a1, a3, d1, d2, [e2f ]t, and H0 are parameters defined in Appendix B, Table
B.4. The parameter a0 can be estimated as follows. Let A(c) be defined as:
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Figure 8: Series of plots showing the scaling analysis of the G1/S transition age. Plot (a) shows
that below the critical value rcr, which corresponds to the value of the ratio p6/p3, above which
there is no transition to quiescence (i.e. if p6/p3 > rcr the G1/S transition age is finite when
c = 0), aG1/S(c, p6, p3) follows an algebraic decay with a universal p6/p3-independent exponent
provided that the oxygen, c, is rescaled by the critical oxygen concentration, ccr(p6/p3). Plot (c)
shows that if, by contrast, p6/p3 > rcr aG1/S(c, p6, p3) decays exponentially with the oxygen
concentration with a characteristic concentration c0 which, provided p6/p3 is larger enough than
rcr, is p6/p3-independent. Plot (b) shows how ccr varies as p6/p3 is changed. Similarly, plot (d)
shows how a+ varies p6/p3 changes. Parameter values as given in Table B.4.
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A(c) =
(
p6
p3
)2(
1− d2
(d2 + d1
a1−a3[H]
a2
)[e2f ]t
)
(15)
where [H] = a3H0eβ1(1−c). a0 = A(cbif ), where cbif is the critical value of the
oxygen concentration for which the saddle node bifurcation occurs, i.e. the critical
value for which the number of real, positive solutions of the equation:
e1(1− x)(J4 + x)(b2 + b3x) = A(c)e2b1m∗[e2f ]tx(1 + J3 − x) (16)
goes from 3 to 1. The parameters bi, ei, and Ji are defined in Appendix B, Table
B.4
4. Cellular scale: Multi-scale Master Equation and path integral formula-
tion
We start by summarising the formulation of the multi-scale Master Equation
(MSME) for the population dynamics model in terms of an age-structured stochas-
tic process [44]. First, we consider a simple age-dependent birth-and-death pro-
cess where n(a, t) stands for the number of cells of age a at time t. Both a and t
are dimensionless according to the scaling prescribed in Table B.3, Appendix B.
The time variable is t → k7ESt and a is defined after Eq. (12). The offspring of
such cells with age a = 0.
P (n, a+ δa, t+ δt) = W (n+ 1, a, t)δtP (n+ 1, a, t)
+(1−W (n, a, t)δt)P (n, a, t), (17)
where W (n(a), a, t) = (ν + b(a))n(a) (see Table 2), µ is the (age-independent)
death rate, and the age-dependent birth rate, b(a), is given by:
b(a) =
{
0 if q8(a) < CycET
τ−1p if q8(a) ≥ CycET (18)
where q8(a) is the generalised coordinate associated with the concentration of
CycE which must exceed a threshold value, CycET for the cell-cycle to progress
beyond the G1/S transition. Before this transition occurs, cells are not allowed to
divide.
By re-arranging Eq. (17) and taking the limit δt = δa→ 0, we obtain:
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Event Reaction Transiton rate, Wk(n, a, t) rk
Birth
n(a)→ n(a)− 1
∅→ n(a = 0) = 2 W1(n, a, t) = b(a)n(a) r1 = −1
Death n(a)→ n(a)− 1 W2(n, a, t) = µn(a) r2 = −1
Table 2: This table summarises the elementary events involved in the age-dependent birth-and-
death process. Cells of age a produce offspring at a rate proportional to the age dependent birth
rate, b(a), Eq. (18). We are assuming that upon cell division both cells are reset to a = 0.
Therefore, upon proliferation, one cell is removed form the population of age a and two cells are
added to the population of age a = 0. For simplicity, death is assumed to be age-independent and
to occur at a rate proportional to the death rate, µ.
∂P (n, a, t)
∂t
+
∂P (n, a, t)
∂a
= W (n+ 1, a, t)P (n+ 1, a, t)
−W (n, a, t)P (n(a), a, t). (19)
where W (n, a, t) = W1(n, a, t) +W2(n, a, t) (see Table 2). Eqs. (19) needs to be
supplemented with the appropriate boundary condition at a = 0, P (n0, a = 0, t).
We proceed by first considering the number of births that occur within the age
group a = aj during a time interval of length δt. Since we are assuming that
our stochastic model is a Markov process where, within each age group, birth and
death occur independently and with exponentially distributed waiting times, the
number of births, B(aj), is distributed according to a Poisson distribution:
P (B(aj) = bj|δt) = e−b(aj)n(aj ,t)δt (b(aj)n(aj, t)δt)
bj
b!
.
The total number of births delivered by the whole population during δt, B, is
B =
∑
i∈I(t)B(aj). Its probability density is therefore given by:
P (B = b0) =
∑
{bj}
(∏
j
Pj(B(aj) = bj)
)
δ∑
j∈I(t) bj ,b0 . (20)
Since Eq. (20) is a convolution, using the well-known property of the probability
generating function, the generating function associated with P (B), GB(p, t) is
given by [68]:
GB(p, t) =
∏
j∈I(t)
Gj(p, t),
21
where Gj(p, t) is the generating function associated with Pj(B(aj)):
Gj(p, t) = e
b(aj)n(aj)δt(p−1).
Therefore, by taking δt = δa→ 0
GB(p, t) = e
(p−1)(
∑
a b(a)n(a))δt. (21)
Eq. (21) determines P (n0, a = 0, t) since P (n0, a = 0, t) = P (B = n0/2, t) and
P (B = b0, t) =
1
b0!
∂b0GB
∂pb0
∣∣∣∣
p=0
. (22)
4.1. Numerical method
Before proceeding further, we briefly describe the numerical methodology that
we use to simulate the stochastic multi-scale model. In essence, the numerical
method is an extension of the hybrid stochastic simulation algorithm used in [71]
to accommodate the age structure of the cell populations we deal with here [44].
For simplicity, we restrict our description of the algorithm to a homogeneous cell
population. Its generalisation to heterogeneous populations composed of a variety
of cellular types is straightforward.
Similarly to the procedure described in [44], we start by defining the popula-
tion vector N (t) = {naj(t), j ∈ J (t)}, where J (t) is the set of indexes which
label all those age groups which, at time t, are represented within the population,
i.e. all those age groups such that n(a = aj, t) > 0. Having defined N (t), we
summarise the numerical algorithm:
1. Set initial conditions: c(t = 0) = c0, n(a, t = 0) = f(a) ⇒ N (t) =
{faj , j ∈ J (t = 0)}, N(t = 0) =
∫∞
0
f(a)da. We also set the value of the
ratio of the SCF-regulating enzymes p6/p3.
2. At some later time t, the system is characterised by the quantities c(t),N (t),
J (t), and N(t)
3. Generate two random numbers, z1 and z2, uniformly distributed in the in-
terval (0, 1)
4. Use z1 to calculate the exponentially distributed waiting time to the next
event: τ = 1
a0(t)
log 1
z1
where a0(t) =
∑
j∈J (t)
(
W1(naj) +W2(naj)
)
. The
rates W1 and W2 are given in Table 2
5. Update the oxygen concentration at c(t+ τ) by solving the associated ODE
Eq. (1) between (t, t + τ) taking c(t) as initial condition. We use a 4 stage
Runge-Kutta solver
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6. Update the age-dependent birth rate for each j ∈ J , i.e.
b(a) = τ−1p H
(
a− aG1/s(c(t+ τ), p6/p3)
)
. The quantity aG1/s(c(t+τ), p6/p3)
is given by Eq. (13)
7. Use z2 to determine which event occurs (i.e. birth or death within the jth
sub-population) at time t+ τ : event l occurs with probability
l∑
k=1
Wk ≤ z2a0(t) <
J∑
k=l+1
Wk,
where J = card(J (t)) andW2(j−1)+1 = W1(naj) andW2(j−1)+2 = W2(naj)
8. If the randomly chosen event is l = 2(j − 1) + 1 (i.e. cell proliferation
within age group j), then naj+τ (t+ τ) = naj(t)− 1, nak+τ (t+ τ) = nak(t)
for all k 6= j, and na=0(t+ τ) = na=0(t) + 2
9. If the randomly chosen event is l = 2(j − 1) + 2 (i.e. cell death within age
group j), then naj+τ (t + τ) = naj(t) − 1, nak+τ (t + τ) = nak(t) for all
k 6= j
10. Finally, we update the set J (t + τ), i.e. the set of age groups for which
naj+τ (t+ τ) > 0
11. Steps 3 to 10 are repeated until some stopping condition (e.g. t ≥ T ) is
satisfied
Note that Step 5 does not involve the use a stochastic method of integration
of the ODE which rules the time evolution of the oxygen concentration, Eq. (1).
This is due to the fact that, within the time interval (t, t+ τ ], the population stays
constant, so that Eq. (1) can be solved by means of a non-stochastic solver.
4.2. Steady-state of a homogeneous population: mean-field analysis
Before proceeding further, in order to check the numerical algorithm proposed
in Section 4.1, we analyse how it compares with results regarding the steady-state
of the mean-field limit of a homogeneous (i.e. composed by one cellular type
only) population [72]. The mean-field equations associated with the stochastic
multi-scale model are:
dc
dt
= S − kNc,
∂Q
∂t
+
∂Q
∂a
= −(ν + b(a))Q (23)
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with boundary condition:
Q(a = 0, t) = 2
∫
b(a)Q(a, t)da.
and birth rate given by:
b(a) = τ−1p H
(
a− aG1/S(c, p6/p3)
)
with aG1/S(c, p6/p3) is given by Eq. (13)
According to [72], in order to ascertain whether a steady-state solution, i.e.
whether the system settles onto an age distribution where the proportion of cells of
each age does not change, we seek for a separable solution: Q(a, t) = A(a)T (t).
Defining µ(a) = ν + b(a), we obtain:
1
T
dT
dt
= − 1
A
(
dA
da
+ Aµ(a)
)
= σ (24)
with σ =cnt. to be determined. Q(a, t) is therefore given by:
Q(a, t) = A(a = 0) exp
(
σ(t− a)−
∫ a
0
µ(y)dy
)
(25)
The value of the parameter σ is obtained by means of the characteristic equation
obtained by introducing Eq. (25) with a = 0 into the boundary condition:
1 = 2
∫ ∞
0
b(a) exp
(
−σa−
∫ a
0
µ(y)dy
)
da (26)
After some algebra, the characteristic equation Eq. (26) reads:
2
τ−1p e
−(σ+ν)aG1/S
σ + ν + τ−1p
= 1 (27)
From Eq. (27) we obtain the condition for the system to be in equilibrium, i.e.
σ = 0. Substituting σ = 0 in Eq. (26):
R0 ≡ 2
τ−1p e
−νaG1/S
ν + τ−1p
= 1 (28)
where R0 is the average number of offspring per cell at equilibrium: if R0 > 1
the system grows exponentially, R0 < 1 the system dwindles, and if R0 = 1 the
24
population remains constant. The equilibrium condition R0 = 1 alllows us to find
the value of aG1/S for which such equilibrium exists:
aG1/S(c∞, p6/p3) = −1
ν
log
(
τp(ν + τ
−1
p )
2
)
(29)
For this quantity to be positive τpν < 1 must hold. This condition states that
for a steady state be reached, the average waiting time to division after the G1/S
transition, τp, must be smaller than the average life span of the cell, ν−1. Eq. (29)
determines the stationary value of the oxygen concentration, c∞.
The long-time dynamics of Eqs. (23) can therefore be summarised as follows:
given the values of τp, ν, and the cell-cycle parameters (see Table B.4 in Appendix
B), the population evolves and consumes oxygen until, the oxygen concentration
reaches a steady value c∞. At this point, the population of resident cells has settled
onto a steady state where its age structure does not change. The total number of
cells is also constant and given by (see Eqs. (23)):
N∞ =
S
kc∞
(30)
In order to verify the age-structured SSA proposed in Section 4.1, we compare
its results with the mean-field predictions, which should be in agreement with
the stochastic behaviour of the system for large values of the carrying capacity,
N∞. Results are shown in Fig. 9. We observe that, as predicted by our steady-
state analysis, the stochastic simulations show how the resident population goes
through an initial (oxygen-rich) phase of exponential growth. As the population
grows, oxygen is depleted and the resident population eventually saturates onto a
number of cells which fluctuates around the mean-field prediction of the carrying
capacity (Eq. (30)).
Further verification of the validity of our numerical methodology is provided
in Fig. 10. Our mean-field theory predicts that, everything else remaining un-
changed, the average steady-state population should increase linearly with the rate
of oxygen delivery, S (see Eq. 30). By contrast, the average equilibrium oxygen
concentration does not depend on S, as shown in Eq. (29), and, consequently, it
should stay constant upon increasing the rate of oxygen delivery. Fig. 10 shows
that our simulations agree with these mean-field predictions.
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Figure 9: Plots showing simulation results of the stochastic multi-scale dynamics of a cell popu-
lation. These plots show how, in agreement with our steady-state analysis, the population evolves
until it reaches a steady-state where the population of resident cells fluctuates around its associ-
ated carrying capacity Eq. (30). Colour code: blue lines show the total resident cell population at
time t, N(t) (panels (a) & (b)). Green lines (panels (c) & (d)) show the associated oxygen con-
centration, c(t). The results shown in this figure correspond to a single realisation of the process.
Parameter values: ν = 2.4 · 10−4, S = 1.57 · 10−2, k = 1.57 · 10−4, τp = 2.4 · 101 in panels (a)
& (c), and τp = 2.4 · 103 in panels (b) & (d).
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Figure 10: Plots showing simulation results of the stochastic multi-scale dynamics of a cell popu-
lation. These plots show how, in agreement with our steady-state analysis, the average population
at equilibrium increases linearly as the rate of oxygen delivery, S, is changed (plot (a)). Also,
in accordance with our mean-field theory, the average, steady-state oxygen concentration remains
unchanged as S increases. Parameter values: ν = 2.4 · 10−4, k = 1.57 · 10−4, τp = 2.4 · 101 in
panels (a) & (c), and τp = 2.4 · 103 in panels (b) & (d). Average has been performed over 100
realisations.
5. Quasi-neutral competition within heterogeneous populations
A problem of fundamental importance in several biological and biomedical
contexts is that of a population composed by a heterogeneous mixture of coex-
isting cellular types. A particularly relevant example of such situation is that of
cancer, where heterogeneity within the cancer cell population is assumed to be a
major factor in the evolutionary dynamics of cancer as well as the emergence of
drug resistance [73, 36, 37, 38]. Within this context, we are interested in (i) ex-
ploring the stability of a co-existing heterogeneous population, and (ii) the effects
such heterogeneity has on the long-term effects a cell-cycle dependent therapy.
The the origins of heterogeneity of cancer cell populations is normally at-
tributed to genetic variability arising from chromosomal instability and increased
mutation rate [36]. Our discussion of the model of the G1/S transition (see Section
3) suggests a different source of heterogeneity associated with stochastic effects
due to intrinsic fluctuations. We have shown, by means of both the SCQSSA
analysis and stochastic simulations, that the relative abundance of SCF-regulating
enzymes, which is quantified in our analysis by the ratio p6/p3 (see Sections 3.5.1,
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3.6 and Appendix A). In Section 3.5.1 we have shown that the timing of the G1/S
transition, and, consequently, the overall birth rate is strongly affected by changes
in this quantity. In view, of this we associate heterogeneity to a distribution of the
abundance of such enzymes, whereby we associate cell phenotypes with different
values of the ratio p6/p3. We further assume that this heterogeneity is hereditary,
i.e. daughter cells inherit the value of the ratio p6/p3 from their mother.
5.1. Competition between two sub-populations
To proceed further, we consider the case of the birth-and-death dynamics
of a heterogeneous population composed by two sub-populations, n1(a, t) and
n2(a, t), competing by a common resource, c(t), which regulates the rate of pro-
gression of the cell-cycle of each cell type. The stochastic dynamics of the whole
population is determined by the associated multi-scale master equation:
∂P (n1, n2, a, t)
∂t
+
∂P (n1, n2, a, t)
∂a
= W1(n1 + 1, n2, a, t)P (n1 + 1, n2, a, t)
+W2(n1, n2 + 1, a, t)P (n1, n2 + 1, a, t)
−(W1(n1, n2, a, t) +W2(n1, n2, a, t))P (n1, n2, a, t).
(31)
whereW1(n1, n2, a, t) = (ν1+b1(a))n1(a, t) andW2(n1, n2, a, t) = (ν2+b2(a))n1(a, t),
ν1 and b1(a) are the (age-independent) death rate and the birth rate of the resident
population, and ν2 and b2(a) are the (age-independent) death rate and the birth
rate of the invader. The quantities b1(a) and b2(a) are determined by the (oxygen-
dependent) rate of cell-cycle progression of each sub-population:
b1(a) = τ
−1
p1
H
(
a− aG1/S(c, p61/p31)
)
, (32)
b2(a) = τ
−1
p2
H
(
a− aG1/S(c, p62/p32)
)
(33)
aG1/S(c, p6/p3) is given by Eq. (13). The concentration of resource (oxygen),
c(t), is determined by the following ODE:
dc
dt
= S − (k1N1 + k2N2)c (34)
where Ni(t) =
∫∞
0
ni(a, t)da for i = 1, 2.
The associated initial conditions are given by:
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P (n1, n2, a, t = 0) = δ(n1(a, t = 0)− n01(a))δ(n2(a, t = 0)− n02(a))
In the remaining of this Section we will consider two cellular populations, res-
ident and invader. Each of these phenotypes are determined in terms of the values
four parameters. The resident cells are characterised by two population-dynamics
parameters, namely, the average time to division after the G1/S transition, τp1 , and
the death rate, ν1. We consider two further parameters, p31 and p61 , associated
with the cell-cycle progression dynamics of the resident cells (see Section 3.4).
Similarly, the invader is characterised by the corresponding parameters: τp2 , ν2,
p32 and p62
5.2. Mean-field coexistence versus quasi-neutral stochastic competition
We proceed to analyse the conditions under which two populations are capa-
ble of long-term coexistence. In particular, we analyse a scenario in which the
mean-field description predicts long term coexistence between within a heteroge-
neous population leads to mutual exclusion of all strands but one through so-called
quasi-neutral stochastic competition [74, 75, 71].
The starting point for our study is the mean-field analysis carried out in Sec-
tion 4.2. According to these results, (mean-field) populations evolve until a con-
centration of oxygen, c∞, is reached so that the associated replication number
R0i(c∞) = 1, i = 1, 2. The replication number of either population is given by:
R01 = 2
τ−1p1 e
−ν1aG1/S1 (c∞,p61/p31 )
ν1 + τ−1p1
and R02 = 2
τ−1p2 e
−ν2aG1/S2 (c∞,p62/p32 )
ν2 + τ−1p2
Therefore, our theory predicts that, provided that there exists c∞ such that:
aG1/S1(c∞, p61/p31) = −
1
ν1
log
(
τp1(ν1 + τ
−1
p1
)
2
)
,
aG1/S2(c∞, p62/p32) = −
1
ν2
log
(
τp2(ν2 + τ
−1
p2
)
2
)
, (35)
is satisfied, long-term coexistence ensues, since the whole system (oxygen, resi-
dent and invader) is able to evolve to a state where both populations are in equilib-
rium (in the sense that R0i(c∞) = 1 for both populations) with the same concen-
tration of oxygen. Furthermore, the number of resident cells, N1, and the number
of invaders, N2, satisfy:
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k1N1 + k2N2 =
S
c∞
(36)
Thus, the mean-field theory predicts that there exist a continuous of fixed points.
The eventual convergence on to a particular point along the line of fixed points
Eq. (36) depends on the initial conditions. Eq. (36) can be further simplified by
assuming k1 = k2 = k, in which case N1 +N2 = K, where K ≡ S/(kc∞) is the
carrying capacity.
This mean-field scenario is the basis for the study of the long-term stochastic
dynamics of two populations which satisfy Eqs. (35), which are equivalent to
R01 = R02 = 1. The reproduction number is the average number of offspring per
cell. We know from elementary considerations [68] that the value of such quantity
allows us to classify birth-death/branching processes. If R0 > 1 the population
grows, on average, exponentially and has a finite probability of eventual survival.
In this case, the process is referred to as super-critical. If R0 < 1 the population
undergoes exponential decline (on average) and the extinction probability is equal
to 1. The last case, in which R0 = 1, the so-called critical case, the population,
on average, stays constant. However, due to effects of noise, extinction occurs
with probability 1, with the probability of survival up to time t asymptotically
tends to PS(t) ∼ t−1 [76]. In our case, both the resident and the invader undergo a
critical stochastic dynamics, where, once the steady state has established itself, the
population evolves very close to the mean-field line of fixed points N1 +N2 = K
until fixation of one of the species (and, consequently, extinction of the other)
occurs.
In order to numerically check this scenario, we could proceed to estimate the
survival probability at time t, PS(t). However, since this quantity exhibits a fat-
tail behaviour, this would be computationally costly. A more efficient method is to
resort to the asymptotic of the extinction time with system size, which in this case
can be identified with the carrying capacity, K [77]. Typically, a quasi-neutral
competition is associated with an algebraic dependence of the average extinction
time of either population, TE , on the system size, in this case determined by the
carrying capacity, K [78, 74, 75]. In Fig. 11 we plot simulation results for the
competition between two identical populations. In particular, we study how the
average extinction time of either population, TE , varies as the carrying capacity
is changed. We observe that this quantity exhibits a linear dependence on the
carrying capacity:
TE ∼ K, (37)
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Figure 11: Simulation results corresponding to the competition between the sub-populations of a
heterogeneous populations. We show how the average extinction time of either population, TE ,
varies as the carrying capacity, K, changes. We observe that the dependence is algebraic (square
root). For simplicity, the two sub-populations are assumed to be identical (i.e. with the same
characteristic parameter values for both the intracellular dynamics (cell-cycle) and the population-
level dynamics (birth and death rates)). The carrying capacity K = Sk1c∞ by varying the death
rates of both populations. The values of are ν = 1.0 · 10−4, 0.83 · 10−4, 0.73 · 10−4, 0.625 ·
10−4, 0.417 · 10−4, which correspond to K = 0.9969 · 103, 1.9301 · 103, 2.6956 · 103, 3.4367 ·
103, 4.2661 · 103, respectively. Averages are done over 500 realisations of the hybrid stochastic
model.
Our scenario produces the same qualitative results as Lin et al. [74] and Kogan
et al. [75] who studied the average extinction time of birth-and-death processes
engaged in quasi-neutral competition. In both papers, the average extinction time
was reported to depend linearly on system size.
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6. Study of the effects of cell-cycle-dependent therapy
In Section 5 we have analysed how the dependence of the cell-cycle progres-
sion on the concentration of SCF-activating and SCF-inactivating enzymes al-
lows us to engineer heterogeneous populations where invasion and coexistence
may occur. In this Section, we further explore the ability of inducing quiescence
by varying the ratio between SCF-activating and SCF-inactivating enzymes, this
time in connection with the ability of such populations to withstand the effects of
cell-cycle-dependent therapy [79, 80, 81, 7].
In particular, we consider an scenario where two cellular populations coex-
ist. Initially, one of these populations consists of a set of cells actively progress-
ing through the cell-cycle which have reached a steady state characterised by the
mean-field equilibrium Eqs. (28)-(30). The second population consists of qui-
escent cells whose cell-cycle is locked into the G0 phase and therefore do not
proliferate. These cells are further assumed to undergo apoptosis at a very slow
rate. More specifically, the ratio SCF-activating and SCF-inactivating enzymes in
the quiescent cell population is such that, for the steady-state level of oxygen for
the active cells (see Eq. (29)), cells are locked into the G1-fixed point (see Fig. 6).
In this Section we show that the presence of a quiescent population within a
heterogeneous population may lead to resistance to cell-cycle-dependent therapy.
In particular, we show that, whereas such therapies effectively reduce or even
eradicate the active cell population, the feedback between the therapy-induced
decrease in cell numbers and the associated increase in oxygen availability can
yield to the quiescent population to enter the active state and thus regrow the
population. In this sense, we claim that the quiescent population has a stem-
cell-like effect whereby, under the action of therapeutic agent, can repopulate the
system [82].
6.1. Mean-field analysis
We start our mean field analysis by considering a heterogeneous population
composed by cells of two types: type 1 and type 2 cells. Type 1 consists of cells
with values of p3 ≡ p31 and p6 ≡ p61 (see Section 3.4) such that cells are actively
progressing through the cell-cycle. Type 2 cells are characterised by values of
p3 ≡ p32 and p6 ≡ p62 so that they are locked in G0 (i.e. not cycling). The
associated mean-field dynamics are given by:
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dc
dt
= S − k1(N1 +N2)c, (38)
∂Q1
∂t
+
∂Q1
∂a
= −(ν1 + b1(a))Q1 (39)
∂Q2
∂t
+
∂Q2
∂a
= −ν2Q2 (40)
with boundary conditions:
Q1(a = 0, t) = 2
∫
b1(a)Q1(a, t)da, Q2(a = 0, t) = 0.
N1(t) and N2(t) are the total cell population of type 1 and type 2 cells, respec-
tively:
N1(t) =
∫
Q1(a, t)da, N2(t) =
∫
Q2(a, t)da.
For simplicity, we assume that both populations consume oxygen at the same rate,
k1. We further assume that ν2  ν1, i.e. type 2 (quiescent) cells die at a much
slower rate than type 1 (active) cells. In Section 4.2, we have already analysed
under which conditions Eqs. (38)-(40) reach a steady state:
R01 ≡ 2
τ−1p1 e
−ν1aG1/S1
ν1 + τ−1p1
= 1 (41)
where R01 is the average number of offspring per cell of type 1 at equilibrium.
The associated equilibrium value of aG1/S1 is then given by:
aG1/S1(c∞, p61/p31) = −
1
ν1
log
(
(τp1ν1 + 1)
2
)
(42)
which determines the steady-state value of the oxygen concentration c∞. At this
point, the population of resident cells has settled onto a steady state where its
age structure does not change. The total number of cells is also approximately
constant and given by:
N1∞ +N2 '
S
k1c∞
(43)
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where we have used the fact that ν2  ν1. The cell-cycle parameters p32 and p62
have been chosen so that, for c = c∞, aG1/S2(c∞, p62/p32)→∞, i.e. type 2 cells
are initially locked into G0 (see Fig. 6).
Once the population reaches this therapy-free quasi-equilibrium state, we as-
sume that a therapy which only acts on proliferating cells is administered. Ex-
amples of such therapies abound in cancer treatment and can take the form of
cell-cycle specific drugs or radiotherapy [79, 80, 81, 7]. We characterise the ef-
ficiency of the therapy by the so-called survival fraction, FS , i.e. the percentage
of cells which survive the prescribed dose. For example, in radiotherapy FS is
usually taken to be given by the linear quadratic model: logFS = − (αD + βD2)
where D stands for the radiation dosage expressed in Grays and α and β are cell
type-specific parameters. In the present context, we do not specify any particular
form of therapy and we simply take FS ∈ [0, 1). Initially, the therapy only affects
type 1 cells (since type 2 are not proliferating). Therapy affects the birth and death
rates of the type 1 population, which now read:
bT1(a) = τ
−1
p1
FSH(a− aG1/S1(c, p31 , p61)) = Fsb1(a) (44)
νT1(a) = ν1 + (1− Fs)b1(a) (45)
The resulting mean-field equation is given by:
∂Q1
∂t
+
∂Q1
∂a
= −(ν1 + b1(a))Q1 (46)
Q1(a = 0, t) = 2FS
∫
b1(a)Q1(a, t)da (47)
The action of therapeutic agent on the active population initially induces a decline
of the population, which, in turn, involves an increase in the available oxygen
concentration. The latter has the effect of accelerating the rate of progression of
type 1 cells through the cell cycle. In the absence of the quiescent population,
eventually both effects would find a balance and the population of active cells
would settle onto a new equilibrium characterised by:
R0T1 ≡ 2FS
τ−1p1 e
−ν1aG1/ST1
ν1 + τ−1p1
= 1 (48)
or, equivalently:
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aG1/S1(cT∞1 , p31 , p61) = −
1
ν1
(
− logFS + log
(
(τp1ν1 + 1)
2
))
(49)
where cT∞1 is the equilibrium oxygen concentration for the type 2 population
with therapy. Note that aG1/S1(cT∞1 , p31 , p61) < aG1/S1(c∞, p61/p31) and there-
fore cT∞1 > c∞ since aG1/S is a decreasing function of the oxygen concentration.
Re-oxygenation during cell-cycle dependent therapy, in particular, radiotherapy,
has been predicted by other models [83].
Consider now the effect of this process on the type 2 cell population which is
initially quiescent. We know that hypoxia-induced arrest of the cell cycle is re-
versible [56, 50], i.e. upon increase of the concentration of oxygen quiescent cells
may re-enter the cell cycle and become proliferating. Re-entry of quiescent cells
into the cell cycle is predicated upon a sufficient increase in the oxygen contrac-
tion: c > cH2(p32 , p62), where the critical oxygen concentration for type 2 cells,
cH2 , depends on the momenta p32 and p62 or, equivalently, on the concentration of
SCF-activating and SCF-inactivating enzymes. Taking this property into account,
one can devise a scenario in which cT∞1 > cH2(p32 , p62) > c∞, i.e the initial
oxygen concentration is such that type 2 cells are quiescent, but, as the therapy is
administered and proceeds to act upon the type 1 cells, the oxygen concentration
increases until it reaches its critical re- entry concentration. At this point, type 2
cells abandon quiescence and become active and competition between type 1 and
type 2 cells ensues.
In order to assess the long-time behaviour of the system, we first study the
equilibrium of the type 2 cell population upon re-entry into cell-cycle progression.
Its mean-field dynamics is given by:
∂Q2
∂t
+
∂Q2
∂a
= −(ν2 + b2(a))Q1 (50)
Q2(a = 0, t) = 2FS
∫
b2(a)Q2(a, t)da (51)
where b2(a) = τ−1p2 H(a − aG1/S2(c, p32 , p62)) and c is determined by Eq. (38).
Recall that, upon re-entering cell-cycle progression, type 2 cells are no longer im-
mune to the therapy. Although in general the survival fraction is type-dependent,
for simplicity we assume that FS has the same value for both cell types. The
equilibrium condition is once again given in terms of the associated reproduction
number, i.e. R0T2 = 1 which yields:
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aG1/S2(cT∞2 , p32 , p62) = −
1
ν2
(
− logFS + log
(
(τp2ν2 + 1)
2
))
(52)
Since ν2  ν1, we have that aG1/S2(cT∞2 , p32 , p62)  aG1/S1(cT∞1 , p31 , p61)
(see Eqs. (49) and (52)). The latter inequality implies that the equilibrium oxygen
concentration for type 2 cell, cT∞2 , is such that cT∞2 < cT∞1 . It is easy to argue
that, in these conditions, the type 2 population out-competes the type 1 cells: for
cT∞2 < c < cT∞1 , the growth rate of type 1 cells is positive whereas the growth
rate of the type 2 cell population is negative (see Eq. (27)). This implies that, upon
application of therapy and provided that cT∞1 > cH2(p32 , p62) > c∞ is satisfied,
the type 1 population declines and it is replaced by the type 2 population.
6.2. Critical dosage
In order to gain some degree of control over the behaviour described in the
previous section, it would be useful to provide an estimate of the critical dosage
above which therapy-induced re-oxygenation is capable of activating quiescent
cells. We characterise the therapy dose by means of the critical survival fraction,
FSC . Recall that the characteristic equation for the oxygen-dependent growth rate,
σ1(c), of the population of active cells is given by:
2FS
τ−1p1 e
−(σ1+ν1)aG1/S1 (c)
σ1 + ν1 + τ−1p1
= 1 (53)
In order to activate the quiescent population the oxygen concentration must raise
above the critical value cH2(p32 , p62). For the oxygen concentration to grow above
this threshold σ1(cH2) < 0 so that the active cell population continues to decline
thus allowing the oxygen concentration to keep on raising. Therefore the critical
value FSC is such that σ1(cH2) = 0, i.e.
FSC =
ν1 + τ
−1
p1
2τ−1p1 e
−ν1aG1/S1 (cH2 (p32 ,p62 )
(54)
If FS < FSC the decrease in the active cell population is enough to provide enough
oxygen for the quiescent population to become active.
This analysis implies that in heterogeneous populations which include quies-
cent sub-populations, the effect of cell-cycle-dependent therapy does not eradicate
the population. Rather the following two scenarios are possible. If cH2(p32 , p62) >
cT∞1 , type 2 cells do not become activated and become eventually extinct, and the
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type 1 cells settle onto the steady state prescribed by Eq. (49). If, by contrast,
cT∞1 > cH2(p32 , p62) > c∞ is satisfied, type 2 cells out-compete type 1 cells and
the system, composed entirely of type 2 cells, settles onto the steady state pre-
scribed by Eq. (52). In this sense, quiescent cells have stem-cell-like behaviour,
in the sense that they can repopulate the system. In this second scenario, therapy
is not completely without virtue since therapy drives the system to be taken over
by a slower-cycling (less aggressive) phenotype.
6.3. Simulation results
In order to check the accuracy of the mean-field analysis carried out in Section
6.2 regarding the critical survival fraction for rescue from quiescence. We start by
showing (Fig. 12) two typical realisations of the stochastic population dynamics
which illustrate the rescue mechanism. In this simulations, we first let the active
population settle on to its steady state. We then apply a sustained therapy with
constant survival fraction. A more aggressive treatment (FS = 0.6 in Fig. 12)
greatly affects the active population: the amount of active cells killed by the ther-
apy induces re-oxygenation of the population above the critical oxygen level for
activation of the quiescent population whereupon the quiescent cells become pro-
liferating. In Figs. 12(a) & (c), we show that upon activation of the quiescent pop-
ulation, a competition between both populations ensues, which eventually leads
to extinction of the active population. A less aggressive therapy (FS = 0.7 in Fig.
12) also induces death of the active population and re-oxygenation. However, in
this case, the latter is not intense enough to induce activation of the quiescent
cells (see Fig. 12(d)) and therefore the active cells will repopulate the system as
the quiescent population stays on its course to eventual extinction, as shown in
Fig. 12(b).
Fig. 13 shows simulation results for the variation of probability of fixation
of the quiescent population as the survival fraction of the therapy, FS changes.
Our simulation results show qualitative agreement with our mean-field theory (see
Sections 6.1 & 6.2): as the survival fraction increases (i.e. the therapy becomes
less efficient), the probability of fixation abruptly decreases from almost certainty
of fixation to almost certainty of extinction. We observe that our mean-field the-
oretical predicts a critical value for FS slightly smaller than the observed when
fluctuations due to finite size effects are present. However, we observe that, as the
carrying capacity of the system is increased, the critical value of FS converges to
the mean-field value.
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Figure 12: Stochastic simulation results showing typical realisations associated with rescue of
quiescence cells (plots (a) & (c)) and recovery of the proliferating population (plots (b) & (d)) upon
application of a cell-cycle dependent therapy. The efficiency of the therapy is characterised by the
survival fraction, FS . Quiescence rescue is achieved when the survival fraction is set to a value
which falls below the critical threshold, Eq. (54). If FS < FSC (plots (a) & (c)), the cell killing
triggered by the therapy is enough to re-oxygenate the population above the activation threshold
of the quiescent cells. By contrast, if FS > FSC (plots (b) & (d)), re-oxygenation is not enough
to rescue latent cells from quiescence. Parameter values: ν1 = 4.167 · 10−5, ν1 = 4.167 · 10−7,
τp1 = τp2 = 2.1 · 10−3, p61p31 = 1,
p61
p31
= 0.989. The subindex “1” corresponds to the active
population whilst the subindex “2” denotes quantities associated with the quiescent population.
The critical oxygen (as defined in Sections 3.5.2 & 3.6) is ccr1 = 0.023 for the active cells and
ccr2 = 0.1 for the quiescent cells. Colour code: I all of the panels in this figure, blue (red) lines
correspond to the time evolution of the total number of proliferating (quiescent) cells and gree
lines, to the time evolution of the oxygen concentration.
38
0.6 0.61 0.62 0.63 0.64 0.65 0.66 0.67 0.68 0.69 0.7
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Survival Fraction, FS
Pr
ob
ab
ilit
y 
in
va
sio
n 
qu
ie
sc
en
t c
el
ls
 
 
S = 100
S = 300
Mean−field critical FS
Figure 13: This figure shows stochastic simulation results regarding the variation of the probability
of fixation of the quiescence population varies the efficiency of a cell-cycle dependent therapy
changes. The efficiency of the therapy is measured in terms of the survival fraction FS . The orange
vertical line represents the mean-field, theoretical critical survival fraction (Eq. 54). We observe
that as the carrying capacity of the system increases, which in these simulations is achieved by
increasing the rate of oxygen supply, S, the results of the stochastic simulations tend towards the
mean-field prediction. Parameter values: ν1 = 4.167 · 10−5, ν1 = 4.167 · 10−7, τp1 = τp2 =
2.1 · 10−3, p61p31 = 1,
p61
p31
= 0.989. The subindex “1” corresponds to the active population whilst
the subindex “2” denotes quantities associated with the quiescent population. The critical oxygen
(as defined in Sections 3.5.2 & 3.6) is ccr1 = 0.023 for the active cells and ccr2 = 0.1 for the
quiescent cells. Each data point corresponds to the average over 500 realisations of the stochastic
population dynamics.
7. Discussion
In this paper, we have presented and studied a stochastic multi-scale model
of a heterogeneous, resource-limited cell population. This model accounts for a
stochastic intracellular dynamics (in this particular case, a model of the oxygen-
regulated G1/S transition) and an age-structured birth-and-death process for the
cell population dynamics. Both compartments are coupled by (i) a model for the
time variation of resource (oxygen) abundance which regulates the rate of cell-
cycle progression, and (ii) a model of the age-dependent birth rate which carries
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out the coupling between the intracellular and the cellular compartments (see Fig.
1 for a schematic representation of the model and Section 2 for a summary of the
model formulation).
Our analysis of the stochastic dynamics of the oxygen-regulated G1/S tran-
sition, which is a generalisation of the mean-field model presented in [50], has
revealed a number of previously unreported properties related to the presence of
fluctuations. In particular, the optimal path theory and the quasi-steady state ap-
proximation allows us to explore the effect of the SCF-regulating enzymes on
the timing of the G1/S transition. The relative abundance of SCF-activating and
inhibiting enzymes regulates the rate at which cells reach the G1/S transition: ex-
cess of SCF-activating enzyme can delay the transition and even rendering the cell
quiescent regardless of oxygen concentration beyond the predictions of the mean-
field model (see Sections 3.5.1 & 3.5.2). Furthermore, we have shown that the ef-
fects on timing of the G1/S transition of the relative abundance of SCF-activating
enzyme give rise to a scaling form dependence of the age to the transition, aG1/S ,
whereby this quantity is a function of aG1/S(c, p6/p3) which takes the form of Eq.
(13) (see Section 3.6). Taken together, these results imply that stochasticity in the
intracellular dynamics naturally generates variability within the population: an
otherwise homogeneous population presents a distribution of birth rates induced
by variability in the relative abundance of SCF-activating enzyme within the pop-
ulation of cells.
This variation in the duration of the cell-cycle allows us to analyse the dynam-
ics of a stochastic heterogeneous population under resource limitation conditions.
To this end, we consider populations formed by sub-populations of cells charac-
terised by differing relative abundance of SCF-activating and inhibiting enzymes.
We further assume that this heterogeneity is heritable (i.e. daughter cells inherited
the ratio of SCF-regulating enzymes from their mother). In this scenario, we have
shown sub-populations within heterogeneous population engage in quasi-neutral
competition: sub-populations of cells get extinct in an average time which is of
the order of the carrying capacity of the system (see Section 5.2). In the context
of modelling cancer cells populations, where heterogeneity is a main contributor
to the complex dynamics of cancer [84, 36, 85, 37, 38], this result is of relevance
since it allows us to estimate the rate at which sub-populations or clones disap-
pear from the tumour. The fact that this rate is proportional to the inverse of the
carrying capacity reveals a highly dynamical scenario where clones are quickly
decaying and being replaced within the tumour. This can have a profound im-
pact in a variety of evolutionary phenomena such as emergence of drug resistant
phenotypes. From the modelling perspective, we should note that quasi-neutral
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competition is a purely stochastic scenario: the mean-field limit predicts coexis-
tence between the corresponding cell types.
We have further explored the issue of emergence of drug resistant cell types
by analysing a case study in which a quiescent population can be rescued from
latency by the application of a cell-cycle dependent therapy. Examples of such
therapies are radiotherapy or cytotoxic drugs designed to target cells in specific
stages of cell cycle progression [79]. In the particular example analysed in Section
6, we have shown that in mixed population composed by active (proliferating)
and quiescent cells, if the drug is not efficient enough (characterised in terms of
its associated survival fraction, FS), quiescent cells are rescued from latency and
eventually reach fixation within the population, i.e. the activated quiescent cells
out-compete the original active cells until the latter population becomes extinct
[82]. It is noteworthy the fact that in this process of quiescence rescue the original
cancer population is replaced by a much more resistant population as the activated
quiescent cells are less sensitive to the therapy than the original active cells.
Our results show that the methods and models presented in this paper are
of great potential importance for the analysis of the complex dynamics of het-
erogeneous populations under resource limitation, in particular for the study of
emergence of drug resistance in heterogeneous cancer cell populations. Several
important issues have been left out of the present work. A major contributor to het-
erogeneity within a cancer cell population is spatial heterogeneity [84, 37] which
is closely related to micro-environmental heterogeneity. A further issue which
should be analysed in depth concerns the scaling properties of the age to the G1/S
transition (see Section 3.6), in particular whether this is a general property of the
cell-cycle dynamics or rather a specific attribute of the stochastic model presented
here. A thorough analysis of these issues falls beyond the scope of the present
paper and are left for future research.
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Appendix A. Summary of the semi-classical quasi-steady state approxima-
tion
In this Appendix, we give a summary of the semi-classical quasi-steady state
approximation (SCQSSA). For a more detailed presentation of the method, the
reader is referred to [32, 34].
Following [32], we formulate the QSS approximation for the asymptotic so-
lution of the CME obtained by means of large deviations/WKB approximations
[86, 87, 88]. An alternative way to analyse the dynamics of continuous-time
Markov processes on a discrete space of states is to derive an equation for the
generating function, G(p1, . . . , pn, t) of the corresponding probabilistic density:
G(p1, . . . , pn, t) =
∑
x
pX11 p
X2
2 · · · pXnn P (X1, . . . , Xn, t) (A.1)
where P (X1, . . . , Xn, t) is the solution of the CME Eq. (3). G(p1, . . . , pn, t) satis-
fies a partial differential equation (PDE) which can be derived from the CME. This
PDE is the basic element of the so-called momentum representation of the Master
Equation [89, 90, 91, 92, 93]. Analytic solutions for the generating function PDE
are seldom available and one needs to resort to approximate solutions, which are
commonly obtained by means of the WKB asymptotic [92]. More specifically, the
(linear) PDE that governs the evolution of the generating function can be written
as:
∂G
∂t
= Hk (p1, . . . , pn, ∂p1 , . . . , ∂pn)G(p1, . . . , pn, t) (A.2)
where the operator Hk is determined by the reaction rates of the CME Eq. (3).
Furthermore, the solution to this equation must satisfy the normalisation condition
G(p1 = 1, . . . , pn = 1, t) = 1 for all t. The operator H is obtained by multiplying
both sides of the CME by
∏n
i=1 p
Xi
i and summing up over all the possible values
of (X1, . . . , Xn).
Eq. (A.2) is a Schro¨dinger-like equation and, therefore, there is a plethora of
methods at our disposal in order to analyse it. In particular, when the fluctuations
are (assumed to be) small, it is common to use WKB methods [86, 87, 94]. This
approach is based on the WKB-like Ansatz that G(p1, . . . , pn, t) = e−S(p1,...,pn,t).
By substituting this Ansatz in Eq. (A.2) we obtain the following Hamilton-Jacobi
equation for the function S(p1, . . . , pn, t):
∂S
∂t
= −Hk
(
p1, . . . , pn,
∂S
∂p1
, . . . ,
∂S
∂pn
)
(A.3)
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Instead of directly tackling Eq. (A.3), we will use the so-called semi-classical
approximation. We use the Feynman path-integral representation which yields a
solution to Eq. (A.2) of the type [90, 95, 86, 96, 97, 98]:
G(p1, . . . , pn, t) =
∫ t
0
e−S(p1,...,pn,Q1,...,Qn)DQ(s)Dp(s), (A.4)
whereDQ(s)Dp(s) indicates integration over the space of all possible trajectories
and S(p1, . . . , pn, Q1, . . . , Qn) is given by [86]:
S(p1, . . . , pn, Q1, . . . , Qn) = −
∫ t
0
(
Hk(p1, . . . , pn, Q1, . . . , Qn) +
n∑
i=1
Qi(s)p˙i(s)
)
ds
+
n∑
i=1
S0,i(pi, Qi), (A.5)
The position operators in the momentum representation have been defined as
Qi ≡ ∂pi with the commutation relation [Qi, pj] = S0,iδi,j . S0,i(pi, Qi) corre-
sponds to the action associated with the generating function of the probability
distribution function of the initial value of each variable, Xi(t = 0), which are
assumed to be independent random variables. The so-called semi-classical ap-
proximation consists of approximating the path integral in Eq. (A.4) by
G(p1, . . . , pn, t) = e
−S(p1,...,pn,t) (A.6)
where p1(t), . . . , pn(t) are now the solutions of the Hamilton equations, i.e. the
orbits which maximise the action S:
dpi
dt
= −∂Hk
∂Qi
(A.7)
dQi
dt
=
∂Hk
∂pi
(A.8)
where the pair (Qi,pi) are the generalised coordinates corresponding to chemi-
cal species i = 1, . . . , n. These equations are (formally) solved with boundary
conditions[97] Qi(0) = xi(0), pi(t) = pi, where xi(0) is the initial number of
molecules of species i.
Eqs. (A.7)-(A.8) are the starting point for the formulation of the semi-classical
quasi-steady state approximation (SCQSSA) [32, 34]. In order to proceed fur-
ther, we assume, as per the Briggs-Haldane treatment of the Michealis-Menten
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model for enzyme kinetics [99, 100], that the species involved in the system un-
der scrutiny are divided into two groups according to their characteristic scales.
More specifically, we have a subset of chemical species whose numbers, Xi, scale
as:
Xi = Sxi, (A.9)
where xi = O(1), whilst the remaining species are such that their numbers, Xj ,
scale as:
Xj = Exj, (A.10)
where xj = O(1). Key to our approach is the fact that S and E must be such that:
 =
E
S
 1. (A.11)
We further assume [34] that the generalised coordinates, Qi, scale in the same
fashion as the corresponding variable Xi, i.e.
Qi = Sqi, (A.12)
where qi = O(1). We refer to the variables belonging to this subset as slow
variables. Similarly,
Qj = Eqj, (A.13)
where qj = O(1), which are referred to as fast variables. Moreover, we assume
that the moment coordinates, pi, are all independent of S and E, and therefore
remain invariant under rescaling.
Under this scaling for the generalised coordinates, we define the following
scale transformation for the Hamiltonian in Eq. (A.5):
Hk(p1, . . . , pn, Q1, . . . , Qn) = kJS
kElHκ(p1, . . . , pn, q1, . . . , qn) (A.14)
where J identifies the reaction with the largest order among all the reactions that
compose the dynamics and kJ is the corresponding rate constant. In the case of
the stochastic model of the G1/S transition J = 7 (see Table 1), as this reaction
is order 3 whereas all the others are of lower order. The exponents k and l corre-
spond to the number of slow and fast variables involved in the transition rate W7,
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respectively. In this particular case we have k = 2 and l = 1. The last step is to
rescale the time variable so that a dimensionless variable, a, is defined such that:
a = kJS
k−1Elt (A.15)
It is now a trivial exercise to check that, upon rescaling, Eqs. (A.7)-(A.8) read
dpi
da
= −∂Hκ
∂qi
, (A.16)
dqi
da
=
∂Hκ
∂pi
, (A.17)
for the slow variables. By contrast, rescaling of the Hamilton equations corre-
sponding to the subset of fast variables leads to:

dpj
da
= −∂Hκ
∂qj
, (A.18)

dqj
da
=
∂Hκ
∂pj
, (A.19)
where  is defined in Eq. (A.11). The QSS approximation consists on assuming
that dpj
da
' 0 and dqj
da
' 0 in Eqs. (A.18)-(A.19),
−∂Hκ
∂qj
= 0, (A.20)
∂Hκ
∂pj
= 0, (A.21)
resulting in a differential-algebraic system of equations which provides us with
the semi-classical quasi-steady state approximation (SCQSSA).
Appendix B. Semi-classical quasi-steady state analysis of the stochastic model
of the G1/S transition
In this appendix we derive the equations of the SCQSSA of the stochastic
model of the G1/S transition as defined by the Master Equation Eq. (3) and the
associated transition rates shown in Table 1. See [32, 34] for details of the proce-
dure. The associated generating function satisfies the following PDE:
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∂G
∂t
= H(p1, . . . , p10, ∂p1 , . . . , ∂p10)G(p1, . . . , p10, t) (B.1)
where the operator H(p1, . . . , p10, Q1, . . . , Q10) ≡ H(p,Q), where Qi ≡ ∂pi
which satisfies the commutation relation [Qi, pj] = S0,iδi,j , is given by:
H(p,Q) = H1(p,Q) +H2(p,Q) +H3(p,Q) +H4(p,Q) +H5(p,Q) +H6(p,Q)
(B.2)
where the full Hamiltonian H(p,Q) has been separated into 6 parts, each corre-
sponding to one of the reactions shown in Fig. 3. Thus,
H1(p,Q) = k4(p4 − p2p3)Q2Q3 + k5(p2p3 − p4)Q4 + k6(p3p5 − p4)Q4, (B.3)
and
H2(p,Q) = k9p8(p2p6−p7)Q7Q8+k7p8(p7−p5p6)Q5Q6Q8+k8p8(p5p6−p7)Q7Q8,
(B.4)
correspond to enzymatic activation and (CycE-mediated) inactivation of SCF (X5),
respectively. H3(p,Q) through to H6(p,Q) are given by:
H3(p,Q) = (k1 − k2)(p1 − 1) + k3(1− p1)Q1, (B.5)
H4(p,Q) = k10m(p8 − 1)p10Q10(1− p9
[e2f ]tot
Q9) + (1− p8)Q8(k11 + k12p5Q5),
(B.6)
H5(p,Q) = k13(p9 − 1) + (1− p9)(k14Q9 + k15p1Q1Q9), (B.7)
H6(p,Q) = k16(p10 − 1) + k17(1− p10)Q10, (B.8)
which are the Hamiltonians associated with synthesis and degradation of CycD
(X1), CycE (X8), Rb (X9), and E2F (X10), respectively.
By re-scaling the coordinate-like variables Qi according to the scaling shown
in Table B.3 (see Section 3.4 and reference [34]) and defining the dimensionless
time as a = k7ESt, the associated Hamilton equations, Eqs. (A.7)-(A.8)
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Dimensionless variables Dimensionless parameters
a = k7ESt  = E/S
q1 = Q1/S [̂e2f ]tot = [e2f ]tot/S
q2 = Q2/S κ1 = k1/(k7ES
2)
q3 = Q3/E κ2 = k2/(k7ES
2)
q4 = Q4/E κ3 = k3/(k7ES)
q5 = Q5/S κ4 = k4/(k7S)
q6 = Q6/E κ5 = k5/(k7S
2)
q7 = Q7/E κ6 = k6/(k7S
2)
q8 = Q8/S κ8 = k8/(k7S)
q9 = Q9/S κ9 = k9/(k7S)
q10 = Q10/S κ10 = k10/(k7ES)
κ11 = k11/(k7ES)
κ12 = k12/(k7E)
κ13 = k13/(k7ES
2)
κ14 = k14/(k7ES)
κ15 = k15/(k7E)
κ16 = k16/(k7ES
2)
κ17 = k17/(k7ES)
Table B.3: Dimensionless variables and parameters corresponding.
dq1
da
= κ1 − κ2 − κ3q1 + κ15(1− p9)q1q9 (B.9)
dq2
da
= −κ4p3q2q3 + κ5p3q4 + κ9p8p6q7q8 (B.10)

dq3
da
= −κ4p2q2q3 + (κ5p2 + κ6p5)q4 (B.11)

dq4
da
= κ4q2q3 − (κ5 + κ6)q4 (B.12)
dq5
da
= κ6p3q4 − p8p6q5q6q8 + κ8p8p6q7q8 + κ12q5q8(1− p8) (B.13)

dq6
da
= κ9p8p2q7q8 − p8p5q5q6q8 + κ8p8p5q7q8 (B.14)

dq7
da
= −κ9p8q7q8 + p8q5q6q8 − κ8p8q7q8 (B.15)
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dq8
da
= (κ9(p2p6 − p7) + κ8(p5p6 − p7))q7q8 + (p7 − p5p6)q5q6q8 + (B.16)
+κ10mp10q10
(
1− p9q9
[̂e2f ]tot
)
− κ11q8 − κ12p5q5q8 (B.17)
dq9
da
= κ10m(1− p8)p10 q9q10
[̂e2f ]tot
+ κ13 − κ14q9 − κ15p1q1q9 (B.18)
dq10
da
= κ10m(p8 − 1)q10(1− p9q9
[̂e2f ]tot
) + κ16 − κ17q10 (B.19)
dp1
da
= −κ3(1− p1)− κ15(1− p9)p1q9 (B.20)
dp2
da
= −κ4(p4 − p2p3)q3 (B.21)

dp3
da
= −κ4(p4 − p2p3)q2 (B.22)

dp4
da
= −κ5(p2p3 − p4)− κ6(p3p5 − p4) (B.23)
dp5
da
= −p8(p7 − p5p6)q6q8 − κ12(1− p8)p5q8 (B.24)

dp6
da
= −p8(p7 − p5p6)q5q8 (B.25)

dp7
da
= −(κ9(p2p6 − p7) + κ8(p5p6 − p7))p8q8 (B.26)
dp8
da
= −(κ9(p2p6 − p7) + κ8(p5p6 − p7))p8q7 − p8(p7 − p5p6)q5q6 (B.27)
−(1− p8)(κ11 + κ12p5q5) (B.28)
dp9
da
= −κ10m(1− p8)p10 p9q10
[̂e2f ]tot
− (1− p9)(κ14 + κ15p1q1) (B.29)
dp10
da
= −κ10m(p8 − 1)p10(1− p9q9
[̂e2f ]tot
)− κ17(1− p10) (B.30)
where  = E/S  1 and the re-scaled parameters κi are given in Table B.3.
Applying the QSSA to the equations for the momenta p3, p4, p6 and p7 associated
with the fast variables, we obtain:

dp3
da
= 0⇒ p4 = p2p3, dp4
da
= 0⇒ p4 = p5p3 (B.31)
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
dp6
da
= 0⇒ p7 = p5p6, dp7
da
= 0⇒ p7 = p2p6 (B.32)
which implies that p2 = p5, which, in turn, yields that p8 = 1 (see Eqs. (B.21)
and (B.24)). Furthermore, the QSSA applied to the equations for the generalised
coordinates associated with the SCF-activating, q3, Eq. (B.11), and the enzyme-
active SCF complex, q7, Eq. (B.15), yields:

dq3
da
= 0⇒ κ5q4 − κ4q2q3 = −κ6q4, dq6
da
= 0⇒ κ8q7 − q5q6 = −κ9q7,
(B.33)
which implies that q2+q5 = pc. Furthermore, since q3+q4 = pe1 and q6+q7 = pe2
are satisfied, we obtain that:
q4 =
pe1q2
q2 +
κ5+κ6
κ4
, q7 =
pe2q5
q5 + (κ8 + κ9)
(B.34)
Finally, using Eqs. (B.31)-(B.34), the SCQSSA equations for the stochastic
model of the G1/S transition are:
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dq1
da
= κ1 − κ2 − κ3q1 + κ15(1− p9)q1q9 (B.35)
dq5
da
=
κ6p3pe1(pc − q5)
(pc − q5) + κ5+κ6κ4
− κ9p8p6pe2q5q8
q5 + (κ8 + κ9)
(B.36)
dq8
da
= κ10mp10q10
(
1− p9q9
[̂e2f ]tot
)
− κ11q8 − κ12p5q5q8 (B.37)
dq9
da
= κ10m(1− p8)p10 q9q10
[̂e2f ]tot
+ κ13 − κ14q9 − κ15p1q1q9 (B.38)
dq10
da
= κ10m(p8 − 1)q10(1− p9q9
[̂e2f ]tot
) + κ16 − κ17q10 (B.39)
q2 = pc − q5 (B.40)
q4 =
pe1q2
q2 +
κ5+κ6
κ4
, q3 + q4 = pe1 (B.41)
q7 =
pe2q5
q5 + (κ8 + κ9)
, q6 + q7 = pe2 (B.42)
dp1
da
= −κ3(1− p1)− κ15(1− p9)p1q9 (B.43)
dp9
da
= −κ10m(1− p8)p10 p9q10
[̂e2f ]tot
− (1− p9)(κ14 + κ15p1q1) (B.44)
dp10
da
= −κ10m(p8 − 1)p10(1− p9q9
[̂e2f ]tot
)− κ17(1− p10) (B.45)
p2 = p5 (B.46)
p4 = p2p3 (B.47)
p7 = p2p6 (B.48)
If we set pi = 1 in Eqs. (B.35)-(B.48), we recover the mean-field model
proposed in [50]. This limit allows us to determine the parameter values of the
stochastic model (see [32, 34] for details). This equivalence is shown in Table
B.4. The parameter values of the mean-field model [50] are given in Table B.5
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